|
|
|
Insider
Information: |
Behrens M Kathleen |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
371,047 |
|
Indirect Shares
|
400,313 |
|
|
Direct
Value |
$22,980,729 |
|
|
Indirect Value
|
$1,228,400 |
|
|
Total
Shares |
771,360 |
|
|
Total
Value |
$24,209,129 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-4.2%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Sarepta Therapeutics Inc |
SRPT |
|
2024-03-01 |
176,839 |
2024-03-01 |
10,000 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Amylin Pharmaceuticals Inc |
AMLN |
Director |
2012-08-08 |
0 |
2011-05-24 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Igm Biosciences, Inc. |
IGMS |
|
2024-03-29 |
10,046 |
2024-03-29 |
390,313 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Mimedx Group Inc |
MDXG |
Director |
2024-06-05 |
184,162 |
2020-08-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
60 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2010-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2011-04-06 |
4 |
B |
$1.50 |
$150,000 |
D/D |
100,000 |
105,000 |
2.39 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Director |
|
2011-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2011-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
110,000 |
0 |
- |
|
AMLN |
Amylin Pharmaceuticals In... |
Director |
|
2012-08-08 |
4 |
D |
$31.00 |
$186,000 |
D/D |
(6,000) |
0 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2012-08-23 |
4 |
A |
$0.00 |
$0 |
D/D |
833 |
19,166 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2012-09-07 |
4 |
B |
$14.58 |
$257,724 |
D/D |
17,500 |
36,666 |
2.39 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2013-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
37,666 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2013-09-16 |
4 |
B |
$37.04 |
$240,778 |
D/D |
6,500 |
44,166 |
2.39 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
45,166 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2015-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
46,166 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2016-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
47,166 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2016-03-14 |
4 |
B |
$16.54 |
$1,075,276 |
D/D |
65,000 |
112,166 |
2.39 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2016-03-16 |
4 |
B |
$14.54 |
$145,433 |
I/I |
10,000 |
21,855 |
2.1 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2017-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
113,116 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2018-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,418 |
116,534 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2018-10-31 |
4 |
OE |
$3.96 |
$39,600 |
D/D |
10,000 |
126,534 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2018-10-31 |
4 |
S |
$131.71 |
$1,317,100 |
D/D |
(10,000) |
116,534 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2019-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,633 |
118,167 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2019-09-05 |
4 |
OE |
$7.80 |
$39,000 |
D/D |
5,000 |
123,167 |
0 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2019-09-06 |
4 |
B |
$87.98 |
$219,950 |
D/D |
2,500 |
125,667 |
2.39 |
- |
|
IGMS |
Igm Biosciences, Inc. |
Director |
|
2019-09-18 |
4 |
B |
$16.00 |
$1,000,000 |
D/D |
62,500 |
62,500 |
2.39 |
- |
|
IGMS |
Igm Biosciences, Inc. |
Director |
|
2019-12-09 |
4 |
B |
$24.26 |
$497,316 |
I/I |
20,000 |
10,000 |
2.1 |
- |
|
SRPT |
Sarepta Therapeutics Inc |
Director |
|
2020-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,075 |
127,742 |
0 |
- |
|
IGMS |
Igm Biosciences, Inc. |
Director |
|
2020-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
357 |
62,857 |
0 |
- |
|
60 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|